Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.
J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff Threats